OrthoPediatrics Corp.

XNASHealth care

Last traded price · USD

$33.51

−0.01%Delayed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 20:05 IST · A quote does not mean the product is available to trade on your account.

Day's open: $33.89
Previous close: $33.51
Volume: 3,446
Day's high: $33.89
Day's low: $33.51

In brief

OrthoPediatrics Corp. is a health care company listed on Nasdaq, valued at about $875M.
Its shares closed at $33.51 on 4 Nov 2026, up 102.1% over the past year.
From India you can buy KIDS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy OrthoPediatrics Corp. (KIDS) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole KIDS share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade KIDS options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Set a 52-week high on 4 Nov 2026
Closed at $33.51 on 4 Nov 2026: 3.0% below the 52-week high of $34.53 (4 Nov 2026) and 132.4% above the low of $14.42 (30 Apr 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Ahead of SPY and its sector fund XLV over 1 year
1 month: +47.6% (SPY −1.6%, XLV +13.5%). 3 months: +50.2% (SPY −0.4%, XLV +15.5%). 1 year: +102.1% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: KIDS, SPY and XLV · as of 4 Nov 2026
RSI(14) at 80.6, 70 or above
The 14-session relative strength index closed at 80.6 on 4 Nov 2026, its 6th session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $33.51 was 41.2% above its 50-day average ($23.73) and 69.6% above its 200-day average ($19.76). It has closed above the 200-day for 107 sessions, since 4 Jun 2026. The 50-day average crossed above the 200-day on 30 Jun 2026, 89 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Volume 1.7× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 555.4K shares was 1.7× the average of the 30 sessions before it (327.6K), as the price rose 6.7%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+47.6%

6 months+95.7%

1 year+102.1%

5 years−53.6%

Newswire

About

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.

Website

Notable moves

October 28, 2026
+29.30%
March 5, 2025
+11.88%
November 14, 2023
+14.73%

OrthoPediatrics Corp.

XNASHealth care

Last traded price · USD

$33.51

−0.01%Delayed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 20:05 IST · A quote does not mean the product is available to trade on your account.

Day's open: $33.89
Previous close: $33.51
Volume: 3,446
Day's high: $33.89
Day's low: $33.51

In brief

OrthoPediatrics Corp. is a health care company listed on Nasdaq, valued at about $875M.
Its shares closed at $33.51 on 4 Nov 2026, up 102.1% over the past year.
From India you can buy KIDS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy OrthoPediatrics Corp. (KIDS) shares from India?

Do I need the price of a whole KIDS share to invest?

How much can I invest in US stocks in a year?

Can I trade KIDS options or futures?

Insights

Quotes run fifteen minutes behind.

Set a 52-week high on 4 Nov 2026
Closed at $33.51 on 4 Nov 2026: 3.0% below the 52-week high of $34.53 (4 Nov 2026) and 132.4% above the low of $14.42 (30 Apr 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Ahead of SPY and its sector fund XLV over 1 year
1 month: +47.6% (SPY −1.6%, XLV +13.5%). 3 months: +50.2% (SPY −0.4%, XLV +15.5%). 1 year: +102.1% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: KIDS, SPY and XLV · as of 4 Nov 2026
RSI(14) at 80.6, 70 or above
The 14-session relative strength index closed at 80.6 on 4 Nov 2026, its 6th session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $33.51 was 41.2% above its 50-day average ($23.73) and 69.6% above its 200-day average ($19.76). It has closed above the 200-day for 107 sessions, since 4 Jun 2026. The 50-day average crossed above the 200-day on 30 Jun 2026, 89 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Volume 1.7× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 555.4K shares was 1.7× the average of the 30 sessions before it (327.6K), as the price rose 6.7%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+47.6%

6 months+95.7%

1 year+102.1%

5 years−53.6%

Newswire

About

Website

Notable moves

October 28, 2026
+29.30%
March 5, 2025
+11.88%
November 14, 2023
+14.73%

OrthoPediatrics Corp.

OrthoPediatrics Corp. in brief

Set a 52-week high on 4 Nov 2026

Ahead of SPY and its sector fund XLV over 1 year

RSI(14) at 80.6, 70 or above

Above its 50- and 200-day averages

Volume 1.7× its 30-session average on 4 Nov 2026

OrthoPediatrics Corp.

OrthoPediatrics Corp. in brief

Set a 52-week high on 4 Nov 2026

Ahead of SPY and its sector fund XLV over 1 year

RSI(14) at 80.6, 70 or above

Above its 50- and 200-day averages

Volume 1.7× its 30-session average on 4 Nov 2026